Zhejiang Bangli Medical Products Co., Ltd FDA Record
- Latest inspection OAI · Aug 17, 2016
- Last warning letter 2017
Zhejiang Bangli Medical Products Co., Ltd has 0 FDA recalls, 1 inspection, 0 510(k) clearances and 1 compliance action on record. FDA has issued 1 warning letter to Zhejiang Bangli Medical Products Co., Ltd, the most recent on Jan 27, 2017.
- Latest inspection
- Aug 17, 2016 · OAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 0 | Nov 11, 2026 (checked Nov 15, 2026, unchanged) | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 0 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 1 | Nov 15, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions | 1 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
Reviewing Zhejiang Bangli Medical Products Co., Ltd as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Zhejiang Bangli Medical Products Co., Ltd yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Zhejiang Bangli Medical Products Co., Ltd FDA Warning Letters
| Issued | Subject | Issuing office | Close-out letter |
|---|---|---|---|
| Jan 27, 2017 · Record page |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Aug 17, 2016 | Yongkang, China | Drugs | Official Action Indicated (OAI) | 3007028032 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
Compliance Actions
FDA's compliance actions data lists 1 compliance action under Zhejiang Bangli Medical Products Co., Ltd: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3007028032 | Yongkang, China | 1 | Aug 17, 2016 |
Zhejiang Bangli Medical Products Co., Ltd and the FDA: common questions
Has Zhejiang Bangli Medical Products Co., Ltd received an FDA warning letter?
Yes. FDA has issued 1 warning letter to Zhejiang Bangli Medical Products Co., Ltd. The most recent is dated Jan 27, 2017.
Has Zhejiang Bangli Medical Products Co., Ltd received an FDA Form 483?
FDA has not published a Form 483 for "Zhejiang Bangli Medical Products Co., Ltd" in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Zhejiang Bangli Medical Products Co., Ltd?
The most recent FDA inspection on file ended Aug 17, 2016 at Yongkang, China and was classified OAI. FDA has 1 inspection of Zhejiang Bangli Medical Products Co., Ltd on file, 1 of them classified OAI (official action indicated).
Need more than this page shows? Ask about Zhejiang Bangli Medical Products Co., Ltd in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.